Russell Investments Group’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Buy
105,553
+65,517
+164% +$1.22M ﹤0.01% 1994
2026
Q1
$726K Sell
40,036
-191,977
-83% -$3.31M ﹤0.01% 2362
2025
Q4
$4.54M Buy
232,013
+118,081
+104% +$2.24M ﹤0.01% 1392
2025
Q3
$1.44M Buy
113,932
+70,007
+159% +$798K ﹤0.01% 2028
2025
Q2
$418K Sell
43,925
-23,952
-35% -$264K ﹤0.01% 2404
2025
Q1
$710K Sell
67,877
-48,852
-42% -$699K ﹤0.01% 2175
2024
Q4
$2.75M Sell
116,729
-6,735
-5% -$199K ﹤0.01% 1493
2024
Q3
$4.43M Buy
123,464
+17,787
+17% +$708K 0.01% 1259
2024
Q2
$3.73M Buy
105,677
+3,734
+4% +$109K 0.01% 1294
2024
Q1
$2.89M Buy
101,943
+1,447
+1% +$32.7K ﹤0.01% 1450
2023
Q4
$1.34M Sell
100,496
-46,650
-32% -$456K ﹤0.01% 1832
2023
Q3
$1.32M Buy
147,146
+35,842
+32% +$386K ﹤0.01% 1782
2023
Q2
$1.25M Buy
111,304
+87,678
+371% +$1.03M ﹤0.01% 1817
2023
Q1
$272K Buy
23,626
+5,737
+32% +$74.5K ﹤0.01% 2416
2022
Q4
$207K Sell
17,889
-15,222
-46% -$176K ﹤0.01% 2560
2022
Q3
$420K Buy
+33,111
New +$380K ﹤0.01% 2311
2021
Q2
Sell
-7,023
Closed -$109K 3232
2021
Q1
$109K Buy
+7,023
New +$136K ﹤0.01% 2967

Other funds holding DYN

Russell Investments Group's DYN Position: Q2 2026 in Review

Russell Investments Group increased its Dyne Therapeutics (DYN) stake by 164% in Q2 2026, buying an estimated $1.22M and bringing the position to 105,553 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

Russell Investments Group first reported a position in DYN in Q1 2021 and has held it in 17 quarters since. The position peaked at $4.54M in Q4 2025. 76 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Russell Investments Group held 105,553 shares of Dyne Therapeutics worth $2.34M as of Q2 2026.
  • Russell Investments Group bought 65,517 Dyne Therapeutics shares in Q2 2026, an estimated $1.22M.
  • Dyne Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1994 holding.
  • Russell Investments Group first reported a position in Dyne Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • Russell Investments Group's Dyne Therapeutics position peaked at $4.54M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.